Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

atoplab.com
 

Enter Stock Symbol:  

TapImmune Inc. (TPIV)

8.34 0.05 (0.6%)

10-17 16:00

Open:

8.26

Pre. Close:

8.29

High:

8.4

Low:

8.01

Volume:

100,153

Market Cap:

376M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

8.413 - 8.447

8.447 - 8.481

Low:

7.929 - 7.963

7.963 - 7.999

Close:

8.282 - 8.343

8.343 - 8.406

Technical analysis  (as of: 2018-10-19 4:39:54 PM)

Overall:

      

Stoxline posted a STRONG BUY today, upgraded from lower rating. This stock seems to be very strong for long buyers. If you bought, continue to hold stock until SELL signal. You are relatively safe as long as the SELL warning is not issued.

Target:

Six months: 10.91     One year: 12.38

Support:

Support1: 7.30    Support2: 6.07

Resistance:

Resistance1: 9.34    Resistance2: 10.60

Pivot:

8.64

Moving Averages:

MA(5): 7.94     MA(20): 8.89

MA(100): 8.51     MA(250): 5.37

MACD:

MACD(12,26): -0.20     Signal(12,26,9): -0.06

%K %D:

%K(14,3): 29.71     %D(3): 18.46

RSI:

RSI(14): 46.32

52-Week:

High: 13.55  Low: 2.58  Change(%): 163.9

Average Vol(K):

3-Month: 20665  10-Days 20188

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
TPIV has closed above bottom band by 36.5%. Bollinger Bands are 35.9% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

2018-10-17T11:45:00-04:00
TapImmune And Marker Therapeutics Announce Successful Closing Of Previously Announced Merger And Financing

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

NA

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Biotechnology

Shares Out. (M)

13.71

Shares Float (M)

8.62

% Held by Insiders

47.90

% Held by Institutions

32.40

Shares Short (K)

1108

Shares Short Prior Month (K)

Stock Financials

EPS

EPS Est. Current Year

-2.210

EPS Est. Next Year

-0.700

EPS Est. Next Quarter

Forward EPS

-1.596

Book Value (p.s.)

28.580

PEG Ratio

Profit Margin

Operating Margin

-7147.91

Return on Assets (ttm)

-162.8

Return on Equity (ttm)

-231.0

Qtrly Rev. Growth

Gross Profit (p.s.)

Sales Per Share

EBITDA (p.s.)

Qtrly Earnings Growth

Operating Cash Flow (M)

-9.25

Levered Free Cash Flow (M)

-3.77

Valuation

P/E

P/E Growth Ratio

P/BV

0.29

P/S

5717070336.00

P/CF

-12.36

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

2016-09-16

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.